Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.
Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
1d
Drug experts have revealed the two telltale signs that a weight loss jab bought online is fake - and could put you at risk of ...
US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with ...
The following is a list of major prescription drugs whose ingredients or components are imported into the United States from the European Union, based on U.S. Food and Drug Administration import data ...
IT’S hard to imagine a time when the word ‘Ozempic’ wasn’t part of our vocabulary. For years, celebs have embraced the ...
Snooker star Stuart Bingham has revealed that he has lost three stone after turning to fat-loss injections. The 2015 world ...
STUART BINGHAM admits he has shed three stone in weight after taking weekly fat-loss injections. The 2015 world snooker ...
The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback